CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +11,280 | $17.76 | $200K | 23,977 |
| 2026-11-09 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −11,280 | $98.54 | $1.1M | 12,697 |
| 2026-11-09 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −11,280 | 5,114 | ||
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +145,763 | $17.92 | $2.6M | 925,800 |
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −1,460 | $92.35 | $135K | 924,340 |
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −11,335 | $93.54 | $1.1M | 913,005 |
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −81,742 | $94.20 | $7.7M | 831,263 |
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −29,845 | $95.48 | $2.8M | 801,418 |
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −26,918 | $96.05 | $2.6M | 774,500 |
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −145,763 | 0 | ||
| 2026-11-03 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +89,089 | $8.83 | $787K | 958,970 |
| 2026-11-03 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +41,237 | $17.92 | $739K | 1,000,207 |
| 2026-11-03 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −1,214 | $90.77 | $110K | 998,993 |
| 2026-11-03 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −68,664 | $92.70 | $6.4M | 930,329 |
| 2026-11-03 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −145,708 | $93.53 | $13.6M | 784,621 |
| 2026-11-03 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −4,584 | $94.25 | $432K | 780,037 |
| 2026-11-03 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −89,089 | 0 | ||
| 2026-11-03 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −41,237 | 145,763 | ||
| 2026-11-02 | Moat Ross CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +9,412 | $18.06 | $170K | 19,706 |
| 2026-11-02 | Moat Ross CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +12,302 | $21.77 | $268K | 32,008 |
Page 1 of 74 · 1,467 trades